HomeCCCC • NASDAQ
C4 Therapeutics Inc
add
$1.54
4.05%
After Hours:(0.64%)-0.0099
$1.53
Closed: Jun 4, 7:10:48 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.24M | 138.17% |
Operating expense | 9.33M | -9.31% |
Net income | -26.32M | 7.19% |
Net profit margin | -363.66 | 61.03% |
Earnings per share | -0.37 | 2.33% |
EBITDA | -28.71M | 2.13% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 215.09M | -16.69% |
Total assets | 319.52M | -19.79% |
Total liabilities | 124.38M | -11.21% |
Total equity | 195.14M | — |
Shares outstanding | 71.01M | — |
Price to book | 0.54 | — |
Return on assets | -21.79% | — |
Return on capital | -26.94% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -26.32M | 7.19% |
Cash from operations | -33.29M | -83.71% |
Cash from investing | 29.13M | 154.55% |
Cash from financing | -46.00K | -100.13% |
Net change in cash | -4.21M | 88.61% |
Free cash flow | -21.35M | -472.93% |
Previous close
$1.48
Day range
$1.47 - $1.57
Year range
$1.09 - $7.66
Market cap
109.35M USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
110
